TFRC and Alzheimer disease: More recently, Lengerich et al. engineered an antibody transport vehicle (ATV) incorporating a monovalent TfR-binding site to enhance TREM2 activation in an AD mouse model, improving brain distribution, microglial function, and glucose metabolism [120].